Course Information
44th Annual UCLA State-of-the-Art Urology Conference

The Ritz-Carlton
Marina del Rey, California
March 08, 2019 to March 10, 2019
*Please note that the course syllabus will be available online only to registered attendees.
A password link will be sent prior to the course.





Download: [ PDF ]

Course Description

This course explores the most challenging management problems facing the practicing urologist. Distinguished faculty present current information and techniques in female pelvic medicine and reconstruction, stress urinary incontinence, nocturia, renal and ureteral stones, surgical therapies and technologies for BPH, diet and supplements for men’s health, pelvic and scrotal pain, testosterone replacement therapy, urologic oncology (prostate, bladder, kidney), imaging (Fluciclovine Scan and PSMA PET) and ablative therapies, biomarkers for cancer detection and management, prostate MRI, active surveillance, robotic surgery pearls, BCG unresponsive bladder cancer, management of the small renal mass, GU dermatology and practice management. The conference emphasizes interaction between participants and faculty and allows ample time for case presentations and group discussions, ensuring an outstanding educational experience for attendees.

Registration Information

Enrollment

Enrollment is limited. Early enrollment is advised. 

To enroll click here.

By Mail

Send the completed enrollment form to:

David Geffen School of Medicine at UCLA
Office of Continuing Medical Education
UCLA State-of-the-Art Urology
10920 Wilshire Blvd., Suite 1060
Los Angeles, CA 90024-6512

By Fax

Fax the enrollment form with charge card information and your authorizing signature to (310) 794-2624.

By Phone

Use your American Express, MasterCard, VISA, or Discover card. Call (310) 794-2620

Course Fees

  • $550 Physicians
  • $350 David Geffen School of Medicine at UCLA Faculty
  • $275 Non-Physicians, Healthcare Professionals
  • $110 Residents (accompanied by a confirmatory letter of status from department chief or training director)

Refunds

Cancellations must be received in writing by February 1, 2019, and will be subject to a $75 processing fee. No refunds will be given after that date. If, for any reason, the course must be canceled, discontinued, or rescheduled by the Office of Continuing Medical Education, a full refund will be provided. You may fax your refund request to 310-794-2624.

Faculty

Course Chair

William J. Aronson, MD

Course Co-Chairs

Craig Canfield, MD
Karim Chamie, MD, MSHS

Guest Faculty

Steven A. Kaplan, MD
Professor of Urology
Icahn School of Medicine at Mount Sinai
Director, The Men’s Health Program
Mount Sinai Health System
New York, New York

Laurence Klotz, MD, CM
Professor of Surgery, University of Toronto
Sunnybrook Chair of Prostate Cancer Research
Division of Urology
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada

Vandana “Wendy” Madkan, MD, FAAD
Mosaic Dermatology of Santa Monica & Beverly Hills
Beverly Hills, California

James M. McKiernan, MD
John K. Lattimer Professor and Chairman
Department of Urology
Columbia University Vagelos College of Physicians & Surgeons
New York-Presbyterian Hospital
New York, New York

Mark A. Moyad, MD, MPH
Jenkins/Pokempner Director of Complementary and Alternative Medicine
Department of Urology
University of Michigan Medical Center
Ann Arbor, Michigan

Mark N. Painter, BA, CPMA
CEO
PRS, LLC
Thornton, Colorado

Marshall L. Stoller, MD
Professor
Department of Urology
University of California, San Francisco
San Francisco, California

J. Christian Winters, MD, FACS
Vice Chancellor of Clinical Affairs & CEO of LSU Healthcare Network
H. Eustis Reily Professor and Chairman, Department of Urology
LSU Health Sciences Center
New Orleans, Louisiana

Evan Y. Yu, MD
Professor, Division of Oncology, Department of Medicine
University of Washington School of Medicine
Member, Clinical Research Division
Fred Hutchinson Cancer Research Center
Seattle, Washington

Department of Urology Faculty*

Mark S. Litwin, MD, MPH
Professor and Chair
Department of Urology
Professor of Health Policy and Management
School of Public Health

William J. Aronson, MD

Z. Chad Baxter, MD

Karim Chamie, MD, MSHS

Arnold I. Chin, MD, PhD

Matthew Dunn, MD

Ja-Hong Kim, MD

Steven E. Lerman, MD

Leonard S. Marks, MD

Jesse N. Mills, MD

Gladys Ng, MD

Victor W. Nitti, MD

Allan J. Pantuck, MD, MS

Nishant D. Patel, MD

Jacob Rajfer, MD

Robert E. Reiter, MD, MBA

Christopher S. Saigal, MD, MPH

Brian Shuch, MD

Jennifer S. Singer, MD

Renea Sturm, MD

UCLA Faculty*

Alexandra Drakaki, MD, PhD
Assistant Professor of Medicine and Urology
Director - Genitourinary Medical Oncology Program
Co-Director of Research, GU Trials Program
Division of Hematology/Oncology
and Institute of Urologic Oncology

Amar U. Kishan, MD
Assistant Professor
Department of Radiation Oncology

Sandy T. Liu, MD
Division of Hematology-Oncology, Department of Medicine
Institute of Urologic Oncology, Department of Urology

Steven S. Raman, MD
Professor of Radiology, Surgery and Urology
Department of Radiology

Karol E. Watson, MD, PhD
Professor of Medicine/Cardiology
Co-Director, UCLA Program in Preventive Cardiology
Director, UCLA Barbra Streisand Women’s Heart Health Program

*David Geffen School of Medicine at UCLA

Program Agenda

Friday, March 8, 2019

Morning
7:00 Registration / Breakfast / Exhibits
7:50 Introductions and Announcements
William J. Aronson, MD
Male and Female Voiding Dysfunction, Reconstruction, Surgical Tips and Tricks
Moderator: Victor W. Nitti, MD
8:00 Female LUTS Workup - What’s Necessary, What’s Not
Victor W. Nitti, MD
8:20 Urodynamics - What’s Important, Technical Considerations
J. Christian Winters, MD, FACS
8:40 Surgical Treatment of Stress Urinary Incontinence - State of the Art
Victor W. Nitti, MD
9:00 Nocturia - A Practical Approach
Steven A. Kaplan, MD
9:20 Break / Exhibits
9:40 Biology of Pelvic Pain - Practical Use of Non-Opioid Alternatives
J. Christian Winters, MD, FACS
10:00 Does Medical Therapy for BPH Make Sense Anymore
Steven A. Kaplan, MD
10:20 New Technologies for Vaginal Health
Victor W. Nitti, MD
10:40 New Technologies for BPH
Steven A. Kaplan, MD
11:00 Panel Discussion and Case Presentations
Moderator: Dr. Victor Nitti
Panel: Drs. Baxter, Kaplan, Kim and Winters
12:00 Lunch
Afternoon
Urolithiasis
Moderator: Matthew Dunn, MD
1:00 ESWL Strategies in 2019
Matthew Dunn, MD
1:15 Tips and Tricks for Endoscopic Management of Urinary Stones
Marshall L. Stoller, MD
1:35 The Mini-Perc - Indications, Technical Aspects
Matthew Dunn, MD
1:50 Practical Metabolic Workup for Stone Disease
Marshall L. Stoller, MD
2:05 Panel Discussion and Case Presentations
Moderator: Dr. Matthew Dunn
Panel: Drs. Patel and Stoller
3:00 Break / Exhibits
GU Dermatology
Moderator: William J. Aronson, MD
3:20 Genitourinary Dermatology - Diagnosis and Management Pearls
Vandana Madkan, MD, FAAD
Men’s Health
Moderator: Jacob Rajfer, MD
3:50 Testosterone Deficiency and Management: AUA 2018 Guidelines Update
Christopher S. Saigal, MD, MPH
4:10 Algorithmic Approach to Scrotal and Post-Vasectomy Pain
Jesse N. Mills, MD
4:30 Diet and Supplements for Prostate and Sexual Health - Fact or Fiction
Mark A. Moyad, MD, MPH
5:00 Panel Discussion and Case Presentations
Moderator: Dr. Jacob Rajfer
Panel: Drs. Mills, Moyad, and Saigal
5:45 Adjourn and Reception

 

Saturday, March 9th, 2019

Morning
6:30 Breakfast / Exhibits
Video Session
7:00 High Risk Disease, Integration of Imaging with Surgical Management
Technical Aspects: T3 Disease, Salvage Lymphadenectomy
Robert E. Reiter, MD, MBA
7:30 Challenges in Robotic Radical Prostatectomy
Nerve Sparing, The Very Large Prostate
Robert E. Reiter, MD, MBA
Prostate Cancer
Moderator: Mark S. Litwin, MD, MPH
8:00 Diagnosis: Contemporary Imaging, Biomarkers, and Biopsy Strategies
Laurence Klotz, MD, CM
8:20 Focal Therapy in 2019 - What’s Approved Now and What’s Next
Leonard S. Marks, MD
8:35 Active Surveillance in 2019 - State of the Art
Laurence Klotz, MD, CM
8:55 Update on Short Course Radiation Therapy: Safety and Efficacy
Amar U. Kishan, MD
9:05 Panel Discussion and Case Presentations
Moderator: Dr. Mark Litwin
Panel: Drs. Kishan, Klotz, Marks, Reiter and Yu
10:00 Break / Exhibits
10:20 Molecular Imaging For Staging and Advanced Disease - Axumin and PSMA
Robert E. Reiter, MD, MBA
10:35 Late Breaking News - Treatment of Oligometastatic Disease
Evan Y. Yu, MD
10:45 Reducing Morbidity and Improving Survival in Men on ADT
Laurence Klotz, MD, CM
11:00 Pragmatic Sequencing Therapy for Castrate Resistant Prostate Cancer
Evan Y. Yu, MD
11:20 Panel Discussion and Case Presentations
Moderator: Dr. Mark Litwin
Panel: Drs. Kishan, Klotz, Marks, Reiter and Yu
12:00 Lunch
Afternoon
Bladder Cancer
Moderator: Mark S. Litwin, MD, MPH
1:05 BCG Unresponsive NMIBC - What To Do Next
Effective Chemotherapy Options - When to Refer for Blue Light
James McKiernan, MD
1:20 Recurrent Low Grade Bladder Cancer
Karim Chamie, MD, MSHS
1:30 BCG Complications and Management
James M. McKiernan, MD
1:45 Making the Immune System Work for the Urologist
Evan Y. Yu, MD
2:00 Panel Discussion and Case Presentations
Moderator: Dr. Mark Litwin
Panel: Drs. Chamie, Chin, Drakaki, Kishan, McKiernan and Yu
2:50 Break / Exhibits
Kidney Cancer
Moderator: Karim Chamie, MD, MSHS
3:10 Focal Therapy Case Study - 65 yo with 3 cm Renal Mass and Renal Insufficiency
Steven S. Raman, MD

Active Surveillance
Brian Shuch, MD

Partial Nephrectomy
James M. McKiernan, MD
3:40 Cytoreductive Nephrectomy: Where Do We Stand Today
James M. McKiernan, MD
3:55 Panel Discussion and Case Presentations
Moderator: Dr. Chamie
Panel: Drs. Liu, McKiernan, Pantuck, Raman and Shuch
5:30 Adjourn

 

Sunday, March 10, 2019

Morning
6:30 Breakfast / Exhibits
Video Session
7:00 Robotic Partial Nephrectomy Pearls
Karim Chamie, MD, MSHS
7:30 BPH - Endourology Pearls
Matthew Dunn, MD
Practice Management
Moderator: Christopher S. Saigal, MD, MPH
8:00 Practice Management
  • CMS Changes for E/M Codes
  • Telemedicine in Urology
  • Surgical Case Coding
  • Modifier -25 Changes Coming
  • New Technology Should I Adopt - A Financial Analysis
Mark N. Painter, BA, CPMA
10:00 Break / Exhibits
Selected Topics of Interest
Moderator: William J. Aronson, MD
10:20 Cardiac Health - What the Urologist Needs to Know
Karol E. Watson, MD, PhD
10:50 Urologic Management of Transgender Patients
Gladys Ng, MD
Moderator: Steven E. Lerman, MD
11:10 What’s New in Pediatric Urology
Steven E. Lerman, MD
11:35 Pediatric Urology Panel Discussion and Case Presentations
Moderator: Steven E. Lerman, MD
Panel: Drs. Singer and Sturm
12:30 Adjourn

Objectives

At the completion of this program, participants should be better able to:

  • Utilize biomarkers and biopsy techniques for prostate cancer detection and active surveillance
  • Determine the role for prostate MRI prior to the first prostate biopsy
  • Determine the role for SBRT for prostate cancer
  • Understand the present and future role for fluciclovine scan and PSMA imaging
  • Manage advanced prostate cancer
  • Understand the present role for focal therapy for prostate cancer
  • Utilize alternative intravesical chemotherapies for bladder cancer
  • Manage the small renal mass
  • Manage GU pelvic pain conditions
  • Treat male and female voiding dysfunction, BPH, nocturia, and kidney stones
  • Counsel patients on the role of diet and supplements in men’s health
  • Treat testosterone deficiency
  • Manage GU dermatologic conditions
  • Navigate coding and related practice management issues

Accreditation

The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA designates this live activity for a maximum of 22 AMA PRA Category 1 Credits TM. Physicians should claim only credit commensurate with the extent of their participation in the activity.

American Society of Radiologic Technologists Credit

Approved by the ASRT for a maximum of 15.75 Category A continuing education credit.

Disclosures

The FDA has issued a concept paper which classifies commercial support of scientific and educational programs as promotional unless it can be affirmed that the program is "truly independent" and free of commercial influence. In addition to independence, the FDA requires that nonpromotional, commercially supported education be objective, balanced, and scientifically rigorous. The policy further states that all potential conflicts of interest of the CME staff and faculty be fully disclosed to the program's participants. In addition, Accreditation Council for Continuing Medical Education policy mandates that the provider adequately manages all identified potential conflicts of interest prior to the program. We at UCLA fully endorse the letter and spirit of these concepts.

The Department of Urology is a California Board of Nursing approved provider (#8888).

Miscellaneous

Location

The Ritz-Carlton, Marina del Rey
4375 Admiralty Way
Marina del Rey, California 90292
310-823-1700 or 800-241-3333
310-823-2404 facsimile
www.ritzcarlton.com/hotels/marina_del_rey

Accommodations

A block of rooms has been reserved at the Ritz-Carlton for conference participants at a special conference rate of $309.00 plus tax per night for single/double occupancy. One night’s deposit is required to guarantee late arrival (after 5 pm). Confirmation of reservations received after February 5, 2019 is subject to availability.

For reservations call 310-823-1700 or 800-241-3333.

Be sure to mention UCLA’s State-of-the-Art Urology Conference when calling in your reservations. You may also visit their website: https://book.passkey.com/go/UrologyConference2019.

Parking

Daytime: $13 valet only
Overnight: $28

Transportation to Hotel from LAX

Taxi or shuttle service is available from Los Angeles International Airport to the Ritz-Carlton, Marina del Rey.